Jaguar Health Eliminates Multiple Preferred Series; 1-for-15 Reverse Split

What Happened
Jaguar Health, Inc. announced two corporate actions in an 8‑K filed Sept. 21, 2026. On Sept. 15, 2026 the company filed Certificates of Elimination with the Delaware Secretary of State to remove the terms of multiple previously designated preferred stock series from its certificate of incorporation and return those shares to authorized but undesignated preferred stock. On Sept. 17, 2026 Jaguar Health effected a 1‑for‑15 reverse split of its common stock, leaving approximately 520,088 shares of common stock outstanding after the split.

Key Details

• Certificates of Elimination filed Sept. 15, 2026 for Series B‑2, C, D, E, F, G, H, I, J, K, L, M, N and O preferred stock.
• All shares of those specified preferred series had been converted, exchanged or otherwise disposed of in accordance with their terms before Sept. 15, 2026; none were outstanding immediately prior to filing.
• The Certificates of Elimination are effective upon filing and are included as Exhibit 3.1 to the 8‑K.
• Reverse stock split was 1‑for‑15, effective Sept. 17, 2026, resulting in ~520,088 post‑split outstanding common shares.

Why It Matters
These filings simplify Jaguar Health’s capital structure by removing the designations and related provisions for multiple preferred share series and returning those authorizations to undesignated preferred stock. The reverse stock split reduces the number of outstanding common shares and changes per‑share metrics (e.g., share count, reported per‑share amounts) going forward, which can affect trading float and stock price comparability. Investors should note the changed share count and refer to the attached Certificate of Elimination for the full legal details.